Literature DB >> 8549010

Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus.

L Rossetti1.   

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM) results from a disruption of normal glucose homeostasis, primarily insulin secretion and hepatic and peripheral insulin action. However, chronic hyperglycemia has been shown in animal models to contribute to impaired insulin secretion as well as to peripheral insulin resistance. Consequently, stringent control measures aimed at ameliorating chronically elevated blood glucose levels may help lessen the cellular "toxic" effect of hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549010

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  16 in total

Review 1.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 2.  Type 2 diabetes mellitus in children and adolescents.

Authors:  M Marcovecchio; A Mohn; F Chiarelli
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

3.  Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.

Authors:  J K Kim; A Zisman; J J Fillmore; O D Peroni; K Kotani; P Perret; H Zong; J Dong; C R Kahn; B B Kahn; G I Shulman
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 4.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

5.  Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.

Authors:  K Arakawa; T Ishihara; A Oku; M Nawano; K Ueta; K Kitamura; M Matsumoto; A Saito
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

6.  Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function.

Authors:  Kyoungmin Park; Qian Li; Net Daş Evcimen; Christian Rask-Madsen; Yasutaka Maeda; Ernesto Maddaloni; Hisashi Yokomizo; Takanori Shinjo; Ronald St-Louis; Jialin Fu; Daniel Gordin; Mogher Khamaisi; David Pober; Hillary Keenan; George L King
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-21       Impact factor: 8.311

Review 7.  Mitochondrial plasticity in obesity and diabetes mellitus.

Authors:  Tomas Jelenik; Michael Roden
Journal:  Antioxid Redox Signal       Date:  2012-10-09       Impact factor: 8.401

8.  SHR3824, a novel selective inhibitor of renal sodium glucose cotransporter 2, exhibits antidiabetic efficacy in rodent models.

Authors:  Pang-ke Yan; Li-na Zhang; Ying Feng; Hui Qu; Li Qin; Lian-shan Zhang; Ying Leng
Journal:  Acta Pharmacol Sin       Date:  2014-05       Impact factor: 6.150

9.  Metabolic adaptations to chronic glucose infusion in rats.

Authors:  B G Topp; M D McArthur; D T Finegood
Journal:  Diabetologia       Date:  2004-09-02       Impact factor: 10.122

10.  Glucose-responsive artificial promoter-mediated insulin gene transfer improves glucose control in diabetic mice.

Authors:  Jaeseok Han; Eung-Hwi Kim; Woohyuk Choi; Hee-Sook Jun
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.